FDA experts gun down a big part of Sanofi's pitch for their controversial vaccine

Sanofi has taken its controversial dengue vaccine to the FDA, but a panel of outside experts just handed down a mixed decision that could reduce — or even eliminate — any market potential it may have in the US.